RXORXO, Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Overbought (RSI 94). Price is +51% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How RXO is trading
RXO, Inc. is +80% over the past year while the S&P 500 is +18%: 62 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +51%
vs 200-day average · a clear uptrend
- RSI (14)
- 94
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 0.82%
Below its 52-week high
Details›
- Last close2026-10-09
- $29.06
- 1 monthS&P 500 +2.7%
- +49%
- 1 yearS&P 500 +18%
- +80%
- vs 50-day average$21.84
- +33%
- 52-week high
- $29.30
- 52-week low
- $10.48
- Annualised volatility
- 69%
| Year | Return |
|---|---|
| 2026 (year to date) | +130% |
| 2025 | −47% |
| 2024 | +2.5% |
| 2023 | +35% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 3 of 4 | +4.7% |
| Feb | 4 | 3 of 4 | +1.3% |
| Mar | 4 | 1 of 4 | −4.5% |
| Apr | 4 | 1 of 4 | −2.8% |
| May | 4 | 4 of 4 | +15% |
| Jun | 4 | 4 of 4 | +11% |
| Jul | 4 | 1 of 4 | +0.27% |
| Aug | 4 | 1 of 4 | −7.2% |
| Sep | 4 | 1 of 4 | −0.54% |
| Oct | 4 | 3 of 4 | +12% |
| Nov | 4 | 2 of 4 | −2.1% |
| Dec | 4 | 1 of 4 | −6.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.